Episode 6: Psychiatric drugs: Symptomatic versus disease-modifying

I discuss my recent article defining psychiatric drugs in two categories: those that improve symptoms and those that affect the underlying disease process. Most psychiatric drugs are symptomatic, and not disease-modifying, and thus should be used less and short-term, in my view. Disease modifying drugs should be used more and long-term. They include lithium and other mood stabilizers.  

The article has generated some discussion on the internet, including some claims with which I don't agree. 

The podcast describes and clarifies the concept. 

The article can be found here:

https://onlinelibrary.wiley.com/doi/abs/10.1111/acps.13459

---

Support this podcast: https://podcasters.spotify.com/pod/show/nassir-ghaemi/support

Get full access to The Psychiatry Letter at ghaemi.substack.com/subscribe